Immune Pharma (IMNP) Reports Q1 Loss of $0.15/Share

Immune Pharma (NASDAQ: IMNP) reported Q1 EPS of ($0.15), versus ($0.35) reported last year.

For earnings history and earnings-related data on Immune Pharma (IMNP) click here.

You May Also Be Interested In

• Walmart (WMT) PT Lowered to $130 at UBS on Investment Narrative's Competing Dynamics
• Bernstein SocGen on Meta Platforms Inc. (META): 'Risk-reward remains attractive'
• Intchains Group Ltd (ICG) PT Lowered to $2 at Benchmark Following 1H Results